Marriott Forecast, price target & analysts
Marriott Target price 2025 - Analyst rating & recommendation
Marriott Classifications & Recommendation:
Marriott Price Target
| Target Price | $295.62 |
| Price | $237.49 |
| Potential | 24.48% |
| Number of Estimates | 21 |
| 21 Analysts have issued a price target Marriott 2026 . The average Marriott target price is $295.62. This is 24.48% higher than the current stock price. The highest price target is $348.00 46.53% , the lowest is $225.00 5.26% . | |
| A rating was issued by 27 analysts: 9 Analysts recommend Marriott to buy, 16 to hold and 2 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Marriott stock has an average upside potential 2026 of 24.48% . Most analysts recommend the Marriott stock at Hold. |
Sales and Margin forecast 2025, 2026 to 2029
17 Analysts have issued a sales forecast Marriott 2025 . The average Marriott sales estimate is $26.4b . This is 5.30% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $27.1b 7.92% , the lowest is $25.7b 2.54% .
This results in the following potential growth metrics:
Revenue Estimates
| 2024 | $25.1b | 5.85% |
|---|---|---|
| 2025 | $26.4b | 5.30% |
| 2026 | $28.0b | 6.12% |
| 2027 | $29.6b | 5.49% |
| 2028 | $29.6b | 0.17% |
| 2029 | $28.5b | 3.72% |
23 Analysts have issued an Marriott EBITDA forecast 2025. The average Marriott EBITDA estimate is $5.4b . This is 33.32% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $5.4b 35.03% , the lowest is $5.3b 31.93% .
This results in the following potential growth metrics and future EBITDA Margins:
EBITDA Estimates
| 2024 | $4.4b | 1.29% |
|---|---|---|
| 2025 | $5.4b | 22.85% |
| 2029 | $7.4b | 14.02% |
EBITDA Margin
| 2024 | 17.41% | 6.74% |
|---|---|---|
| 2025 | 20.31% | 16.65% |
| 2029 | 25.94% | 18.45% |
16 Marriott Analysts have issued a net profit forecast 2025. The average Marriott net profit estimate is $2.8b . This is 22.17% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $3.0b 28.77% , the lowest is $2.7b 18.75% .
This results in the following potential growth metrics and future Net Margins:
Net Profit Estimates
| 2024 | $2.3b | 18.17% |
|---|---|---|
| 2025 | $2.8b | 22.02% |
| 2026 | $3.1b | 11.75% |
| 2027 | $3.6b | 13.82% |
Net Margin
| 2024 | 9.18% | 22.69% |
|---|---|---|
| 2025 | 10.64% | 15.88% |
| 2026 | 11.20% | 5.26% |
| 2027 | 12.09% | 7.95% |
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029
16 Analysts have issued a Marriott forecast for earnings per share. The average Marriott EPS is $10.16 . This is 22.12% higher than earnings per share in the financial year 2024. The highest EPS forecast is $10.71 28.73% , the lowest is $9.88 18.75% .
This results in the following potential growth metrics and future valuations:
Earnings Per Share
| 2024 | $8.33 | 18.17% |
|---|---|---|
| 2025 | $10.16 | 21.97% |
| 2026 | $11.36 | 11.81% |
| 2027 | $12.93 | 13.82% |
P/E ratio
| Current | 28.55 | 19.21% |
|---|---|---|
| 2025 | 23.36 | 18.18% |
| 2026 | 20.91 | 10.49% |
| 2027 | 18.37 | 12.15% |
Based on analysts' sales estimates for 2025, the Marriott stock is valued at an EV/Sales of 3.04 and an P/S ratio of 2.48 .
This results in the following potential growth metrics and future valuations:
EV/Sales
| Current | 3.20 | 8.83% |
|---|---|---|
| 2025 | 3.04 | 4.91% |
| 2026 | 2.87 | 5.76% |
| 2027 | 2.72 | 5.20% |
| 2028 | 2.71 | 0.17% |
| 2029 | 2.82 | 3.87% |
P/S ratio
| Current | 2.61 | 12.45% |
|---|---|---|
| 2025 | 2.48 | 5.03% |
| 2026 | 2.33 | 5.76% |
| 2027 | 2.21 | 5.20% |
| 2028 | 2.21 | 0.17% |
| 2029 | 2.29 | 3.87% |
Current Marriott Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Truist Securities |
Hold
➜
Hold
|
Unchanged | Mar 21 2025 |
| Morgan Stanley |
Overweight
➜
Overweight
|
Unchanged | Mar 04 2025 |
| Wells Fargo |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Feb 18 2025 |
| UBS |
Neutral
➜
Neutral
|
Unchanged | Feb 12 2025 |
| Truist Securities |
Hold
➜
Hold
|
Unchanged | Feb 12 2025 |
| Mizuho |
Neutral
➜
Neutral
|
Unchanged | Feb 12 2025 |
| Susquehanna |
Neutral
➜
Neutral
|
Unchanged | Feb 12 2025 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
Truist Securities:
Hold
➜
Hold
|
Mar 21 2025 |
|
Unchanged
Morgan Stanley:
Overweight
➜
Overweight
|
Mar 04 2025 |
|
Unchanged
Wells Fargo:
Equal-Weight
➜
Equal-Weight
|
Feb 18 2025 |
|
Unchanged
UBS:
Neutral
➜
Neutral
|
Feb 12 2025 |
|
Unchanged
Truist Securities:
Hold
➜
Hold
|
Feb 12 2025 |
|
Unchanged
Mizuho:
Neutral
➜
Neutral
|
Feb 12 2025 |
|
Unchanged
Susquehanna:
Neutral
➜
Neutral
|
Feb 12 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
